Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Atlantic raises $24M venture round

March 22, 2016 1:11 AM UTC

Atlantic Healthcare plc (Cambridge, U.K.) raised $24 million in a venture round from Lorin Johnson and other founders of Salix Pharmaceuticals Inc., Fullbrook Thorpe Investments, LDC and undisclosed existing investors.

In 2H17, Atlantic expects results from a Phase III study of alicaforsen ( AP 1007) to treat inflammatory bowel disease (IBD) pouchitis. Atlantic has exclusive, worldwide rights to the antisense inhibitor of intercellular adhesion molecule-1 ( ICAM-1; CD54) from Ionis Pharmaceuticals Inc. (NASDAQ:IONS). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article